The word enthusiasm comes to mind when you meet Dr. Slack, MD and her team. Even the building itself has an air of newness and excitement. Dr. Slack begins to tell me about what is available at Imber and Im surprised that I have never heard of several of these treatments.
I see her face light up as she explains how much these treatments have helped people. And that for some, aesthetics treatments can be better than Prozac! The latest treatment acquired is the EMSCULPT. This is a machine that uses magnetic energy to initiate contractions of the muscles 20,000 contractions in 30 minutes to be exact!
This leads to formation of new muscle fibers and improvement in core strength that continues for years! Studies show that EMSCULPT not only increases muscles but induces 20% fat reduction (as a glorious side effect). These results have been confirmed by MRIs so there is no guesswork as to the devices effectiveness. What is amazing about this machine is that you get the benefits of doing 20,000 sit-ups while lying down and relaxing. No sweating, no pain, no shortness of breath or increase in heart rate.
This is a fantastic option for anyone who has trouble building up their muscles because of time constraints, back pain, child- birth or even hitting that dreaded plateau at the gym. Ladies love the flat stomachs, toned abs and improvements in physical ability appreciated during yoga, pilates, and tennis! Men have become huge fans after seeing how the results of strengthening ones core affects their golf game!
We first realized there was a demand for EMSCULPT in the Golden Isles when several existing clients expressed how much it had helped their back pain when treated with EMSCULPT at an Atlanta clinic says Dr. Slack. What sold our team was the before and after pictures which speak for themselves. But I was even more impressed with the data and shocked to learn that this device is the only non-surgical, FDA approved option for treatment for diastasis recti (the separation of stomach muscles that occurs during pregnancy). Life brings a lot of changes and how we look, and feel can greatly impact our confidence. What Imber offers is the latest solutions that are proven to work.
EMSCULPT is also FDA approved for building the muscles of the abs, glutes, arms and legs. I cant help but think that this is the perfect time of year. Valentines Day, and shorts season will be here before we know it!
Dr. Slack goes on to list other novel treatments. She shares with me information on Verju, a FDA approved, pain-free, non-surgical, fat reducing (non-hot, non- cold) laser. That consistently delivers results of 4 inch overall circumference reduction after just 6 treatments.
If that wasnt enough to blow my mind she went on to tell me about PDO Threads. She describes how these FDA approved threads can lift the face and smooth out wrinkles while building collagen. Plasma Pen was mentioned next. which is an FDA approved treatment for a non-surgical eyelid lift and wrinkle removal. PRP (Platelet Rich Plasma) is another option in the fight to revitalize the skin. Like the Plasma Pen, PRP is 100% natural and organic which is important to the Imber team!
Even the staples of aesthetics like Botox and filler treatments are taken to a whole new level. Dr. Slack is so proud of her team consisting of herself as an aesthetics board certified MD and advanced registered nurse practitioners. Imbers master injector, Bianca Trevino ARNP, is also board certified in aesthetics and able to provide Botox injections in areas I had never heard of! She can upturn the corners of a down turned mouth, lower the lip of a gummy smile, prevent the tip of a nose from pulling down, provide brow lifts, jaw definition, fine line and wrinkle reduction with micro-Botox and even eliminate neck bands! With regard to filler, the advanced training really shows with their results in providing a natural and youthful appearance, never looking overdone. Imber has virtually every toxin and filler available and the knowledge of what needs to be used when. Bioidentical hormone therapy, IV hydration therapy, hair restoration for men and women, intimacy treatments, jaw contouring, medical assisted weight loss, scar revision, acne treatment and so much more is offered at Imber.
When combining the above treatments with medical grade products (including stem cell and sun protection) sold at Imber: prevention, correction and maintenance are all optimized.
In finishing up my visit, Dr. Slack tells me Our clinics goal is to provide the latest FDA approved solutions available to help all of the Golden Isles look and feel like the best version of themselves. We are so blessed to be a part of this wonderful community and look forward to giving it the best the World has to offer.
If you would like to learn more, Imber hosts a Thirsty Thursday event every 3rd Thursday of the month for those who Thirst for Knowledge ...or wine! Join Imber Jan 16th to learn more about Emsculpt or any other services Imber offers!
Excerpt from:
Imber Medical has what we've all been waiting for - Brunswick News
- Exploring the potential of stem cell-based therapy for aesthetic and plastic surgery - Newswise - December 23rd, 2021
- Avra, Inc. Completes its Merger with Springs Rejuvenation, LLC, a Stem Cell and Anti-Aging Treatment Company - Yahoo Finance - December 23rd, 2021
- Cancer Stem Cell Therapy Market opportunities, threats, main drivers, and key restraints and COVID-19 analysis to 2026 | Advanced Cell Diagnostics,... - December 9th, 2021
- Hiltzik: The battle against unlicensed stem cell clinics - Los Angeles Times - November 8th, 2021
- Cell therapy biotech PlateletBio reels in $75M as it looks ahead to first clinical test - MedCity News - November 8th, 2021
- VDH: Cases surge again to third-worst on record - Vermont Biz - November 8th, 2021
- Blood and bone marrow stem cell donation - Mayo Clinic - October 16th, 2021
- Global Stem Cell and Primary Cell Culture Medium Market 2021 Trends and Leading Players Analysis 2027 Merck, STEMCELL Technologies, Irvinesci, Cell... - October 16th, 2021
- Resilience commits $30M to launch new biotechs out of Harvard with focus on therapeutics, biomanufacturing - FierceBiotech - October 16th, 2021
- Selma Blair Shares That Shes Now in Remission 3 Years After MS Diagnosis - Self - August 18th, 2021
- Third dose of COVID-19 vaccine to be offered to certain residents - Martins Ferry Times Leader - August 18th, 2021
- Friends, family continue Jocelyn's drive to increase stem cell donors - Chatham This Week - August 18th, 2021
- Calidi Biotherapeutics Announces Exclusive License Agreement with City of Hope and the University of Chicago for Novel Oncolytic Virotherapy... - August 18th, 2021
- LSU Health Shreveport Vaccine Clinic at 2726 Linwood Avenue to Begin Administering Third Doses of Vaccine Tomorrow for Those Who Meet CDC Requirements... - August 18th, 2021
- Eagle County begins offering third vaccine doses to the immunocompromised - Vail Daily News - August 18th, 2021
- CDC: Third Dose Of COVID-19 Vaccine Recommended For Moderately & Severely Immunocompromised Individuals Only - KSST - August 18th, 2021
- New CEO, check. $172M round, check. Wugen's off-the-shelf cell therapies are ready for takeoff - FierceBiotech - July 22nd, 2021
- Arbor Strengthens Focus on Therapeutics with Key Additions to Leadership Team - Yahoo Finance - July 22nd, 2021
- For Patients with HIV and Cancer, a Multidisciplinary Treatment Approach is Critical - Targeted Oncology - July 22nd, 2021
- Keeping the physical appointment was critical, the show of support appreciated by Renville County Commissioner - West Central Tribune - May 15th, 2021
- Appia Bio aims for a new kind of off-the-shelf CAR-T with $52M raise - FierceBiotech - May 15th, 2021
- Experimental treatments risk further medicalisation of menopause - The BMJ - May 15th, 2021
- Biopreservation Market Know the diverse technological advancements in the biopreservation - BioSpace - May 15th, 2021
- Reawakened immune cells attack cells tied to diseases of aging - STAT - STAT - May 15th, 2021
- Global Stem Cell Therapy Market Analysis and Forecast (2019-2024) The Courier - The Courier - May 3rd, 2021
- Cell Therapy Company Raises $160 Million to Advance iPSC-Derived Therapies to Clinic - BioSpace - March 8th, 2021
- Retracing the Lineage of Cancer Cells - Technology Networks - March 8th, 2021
- QC Kinetix (Myrtle Beach) Offers Stem Cells Therapy, An Alternative to Surgery For Pain Management in Myrtle Beach, SC - Press Release - Digital... - March 8th, 2021
- Caribou nets $115M to boost CRISPR tech, advance off-the-shelf cell therapies - FierceBiotech - March 8th, 2021
- QC Kinetix (San Antonio) Offers Non-Surgical Regeneration Therapy To Treat Aches, Pains, and Injuries In Individuals Around San Antonio - Press... - March 8th, 2021
- New Research Study Investigates Metformin as a Therapy to Promote Brain Repair and Reduce Disability in Children and Young Adults with MS -... - February 2nd, 2021
- #FillTheSeats to save lives this February with Canadian Blood Services - Sportsnet.ca - January 30th, 2021
- Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes... - January 30th, 2021
- ClearPoint Neuro, Inc. Announces Expansion of Pre-Clinical and Translational Development Team to Support Gene and Stem Cell Therapy Partners -... - January 30th, 2021
- Cell Therapy Market 2020 Industry Size, Share, Segmentation, Comprehensive Analysis and Forecast by 2025 KSU | The Sentinel Newspaper - KSU | The... - January 30th, 2021
- TScan Moves Toward the Clinic with $100 Million Series C Round - BioSpace - January 30th, 2021
- Love Your Skin: What Is SPF And Why Is It Important? - Yahoo Movies Canada - January 30th, 2021
- Caladrius Biosciences Treats First Patient in the Phase 2b FREEDOM Trial of CLBS16 for the Treatment of Coronary Microvascular Dysfunction - Cath Lab... - January 30th, 2021
- From hacking the immune system at the Parker Institute to decoding and reprogramming human cells - leading clinical immunotherapies developer Ramy Ibr... - January 30th, 2021
- City Awards $38 Million in Infrastructure Grants for City Science Institutions - CityLand CityLand - CityLand - January 30th, 2021
- Mesoblast Limited: Is Stemcell Therapy Ready For Prime Time? - Sick Economics - January 22nd, 2021
- Caladrius Biosciences Treats First Patient in the Phase 2b FREEDOM Trial of CLBS16 for the Treatment of Coronary Microvascular Dysfunction | DNA RNA... - January 22nd, 2021
- Breakthrough motor neurone disease study finds way to reverse damage - The National - January 19th, 2021
- Orchard Therapeutics Announces 2021 Corporate Priorities Supporting the Build-out of its Commercial Business in Hematopoietic Stem Cell (HSC) Gene... - January 12th, 2021
- Cancer Stem Cell Therapy Market : Information, Figures And Analytical Insights 2020-2026 - LionLowdown - January 5th, 2021
- Paint it all Pink winner charity donation helps Elizabeth Wende Breast Care Fund - MPNnow.com - December 22nd, 2020
- Center for Regenerative Medicine - Mayo Clinic - December 17th, 2020
- Cancer Stem Cell Therapy Market Revenue, Global Forecast, Cost, Key Participants and Emerging Trends and Key Players-AVIVA BioSciences , AdnaGen - The... - December 12th, 2020
- Cancer Stem Cell Therapy Market Analysis With Key Players, Applications, Trends And Forecasts To 2026 - Cheshire Media - December 5th, 2020
- Short Redhead Reel Reviews for the week of Dec. 4 - ECM Publishers - December 5th, 2020
- Human sperm stem cells grown in lab, an early step toward infertility treatment - Jill Lopez - November 18th, 2020
- Global Stem Cell and Primary Cell Culture Medium Industry 2020 Market Research With Size, Growth, Manufacturers, Segments And 2026 Forecasts Research... - November 18th, 2020
- Updated: FDA gives Cellectis all clear after patient death halted off-the-shelf CAR-T trial - Endpoints News - November 18th, 2020
- FUJIFILM Cellular Dynamics and Lonza Agree to Expand the Availability and Use of Induced Pluripotent Stem Cell Technology - BioSpace - November 16th, 2020
- Cleveland Clinic team draws a link between COVID-19 protection and the sleep aid melatonin - FierceBiotech - November 16th, 2020
- Global Cancer Stem Cell Therapy Market Outlook by Types, Applications, End Users and Opportunities to 2025 - TechnoWeekly - November 16th, 2020
- Orphan Drug Designation Granted for CSL Behring's Investigational Plasma-Derived Hemopexin Therapy for Sickle Cell Disease - PRNewswire - November 3rd, 2020
- What's On The Ballot? Here's A Look At California's 2020 Propositions - KPBS - November 3rd, 2020
- The Animal Stem Cell Therapy market to witness remarkable disruptions in the next decade - TechnoWeekly - October 28th, 2020
- Dr. Hill on Next Steps for Research Exploring CAR T-Cell Therapy in MCL - OncLive - October 28th, 2020
- Randomized Controlled Study Using Direct Injection of Remestemcel-L Into Inflamed Gut of Patients With Crohn's Disease and Ulcerative Colitis -... - October 24th, 2020
- Stem cells, repair cells, & growth factors: What is the latest? - The Times of India Blog - October 20th, 2020
- Cell Therapy Market Trend,COVID-19 Impact,Current Industry Figures With Demand By Countries And Future Growth - PRnews Leader - October 20th, 2020
- Global and United States Cancer Stem Cell Therapy Market Leading Players Expected to Witness the Highest Growth 2025 | AVIVA BioSciences, AdnaGen,... - October 20th, 2020
- Stem Cell and Primary Cell Culture Medium Market Share, By Product Analysis, Ap - News by aeresearch - October 20th, 2020
- Months after achieving unicorn status, Orca steers into the fast lane with an RMAT designation for cell therapy candidate - Endpoints News - October 15th, 2020
- EdiGene Gets $67 Million Infusion to Bring Gene Editing to the Clinic - BioSpace - October 15th, 2020
- CAR T-cell Therapies for the Treatment of Patients with Acute Lymphoblastic Leukemia - OncoZine - October 15th, 2020
- Bone Therapeutics' allogeneic cell therapy product, ALLOB, shows 90% fusion rate at 24 months in Phase IIa study in lumbar spinal fusion -... - October 15th, 2020
- Biopharma Money on the Move: October 7-14 - BioSpace - October 15th, 2020
- Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma. - UroToday - October 8th, 2020
- Around Town: Life is a series of choices a look at California's ballot propositions - VVdailypress.com - October 8th, 2020
- League of Women Voters Releases Their Proposition recommendations - Valley Voice - October 8th, 2020
- Expansion Therapeutics Names Renato Skerlj, Ph.D., Chief Executive Officer and President - BioSpace - October 8th, 2020
- What is the difference between ventilation and respiration? - EMS1.com - October 8th, 2020
- Props to you, Californians: A preview of what's on your November ballot - Palo Alto Online - October 8th, 2020
- TreeFrog Therapeutics and Invetech Expand Partnership to Transition High-throughput Stem Cell Encapsulation Technology to GMP System for... - October 8th, 2020
- How to Vote This November: A Progressive's Opinion Redheaded Blackbelt - Redheaded Blackbelt - October 1st, 2020
- Cancer Stem Cell Therapy Market Size is Thriving worldwide with Topmost Companies Like: Advanced Cell Diagnostics, Silicon Biosystems, Cancer Stem... - September 30th, 2020
- Cell Therapy Manufacturing Market to be Worth USD 8 billion by 2030, predicts Roots Analysis - The Daily Chronicle - September 25th, 2020
